Disruption in immune system markers [pro- and anti-inflammatory substances (e.g., C-reactive protein, interleukin-6, adiponectin, or cell-mediated immunity)] contributes to increased risk of infections, as well as the development of autoimmune disorders or other chronic disorders, including those associated with pain (85). This evidence concerns the gene ADIPOQ and infection.